TR8 Stock Chart & Stats
€74.50
-€1.50(-1.97%)
At close: 4:00 PM EDT
€74.50
-€1.50(-1.97%)
Day’s Range― - ―
52-Week Range€44.40 - €85.00
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€688.95M
Enterprise Value€1.01K
Total Cash (Recent Filing)€6.71M
Total Debt (Recent Filing)€143.25M
Price to Earnings (P/E)231.0
Beta0.53
Next Earnings
Nov 02, 2026EPS Estimate
0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.37
Shares Outstanding9,359,813
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-9.64
Price to Book (P/B)2.35
Price to Sales (P/S)2.42
P/FCF Ratio26.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€86.11Price Target Upside15.59% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)1.52
Revenue Forecast (FY)€313.35M
Bulls Say, Bears Say
Bulls Say
Mergers And AcquisitionsThe acquisition of Essco Calibration is expected to add substantial revenue and is seen as part of the company's growth strategy.
ProfitabilityTRNS shares are expected to trade at a premium due to high visibility recurring revenue and profitability.
Revenue GrowthThe recommendation is to buy TRNS shares due to anticipated revenue growth and expanding gross margins.
Bears Say
Capital RisksRisks include dilution risk from raising additional capital.
Customer DependencyRisks include customer concentration, which could affect stability.
Market CompetitionRisks include increased competition and share volatility.
Transcat News
TR8 FAQ
What was Transcat’s price range in the past 12 months?
Transcat lowest stock price was €44.40 and its highest was €85.00 in the past 12 months.
What is Transcat’s market cap?
Transcat’s market cap is €688.95M.
When is Transcat’s upcoming earnings report date?
Transcat’s upcoming earnings report date is Nov 02, 2026 which is in 56 days.
How were Transcat’s earnings last quarter?
Transcat released its earnings results on Aug 04, 2026. The company reported €0.121 earnings per share for the quarter, missing the consensus estimate of €0.327 by -€0.206.
Is Transcat overvalued?
According to Wall Street analysts Transcat’s price is currently Undervalued.
Does Transcat pay dividends?
Transcat does not currently pay dividends.
What is Transcat’s EPS estimate?
Transcat’s EPS estimate is 0.39.
How many shares outstanding does Transcat have?
Transcat has 9,359,813 shares outstanding.
What happened to Transcat’s price movement after its last earnings report?
Transcat reported an EPS of €0.121 in its last earnings report, missing expectations of €0.327. Following the earnings report the stock price went up 0.629%.
Which hedge fund is a major shareholder of Transcat?
Currently, no hedge funds are holding shares in DE:TR8
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Transcat Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€86.11 (15.59% Upside)
€86.11 (15.59% Upside)
Blogger Sentiment
Neutral
DE:TR8 Sentiment 50%
Sector Average 57%
Sector Average 57%
Insider Transactions
Sold Shares
Worth €496.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
10.08%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
25.50%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Transcat
Transcat, Inc. is a provider of accredited calibration and laboratory instrument services, and a value-added distributor of professional grade test, measurement, and control instrumentation. The company operates through two segments, Service and Distribution, and focuses on providing services and products to highly regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, and medical device businesses.
TR8 Company Deck
TR8 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong, broad-based operational momentum—particularly in Services—with double-digit top-line growth, robust Service profitability expansion, improved adjusted EBITDA, and positive free cash flow trends. Management acknowledged and quantified near-term headwinds (Distribution margin pressure from prior-year comps, higher GAAP costs from acquisitions and executive transition, and some one-time OpEx), but positioned these as manageable and largely transitory while reinforcing a clear strategy (organic growth, operational excellence, and M&A) expected to drive continued margin expansion and market share gains.View all DE:TR8 earnings summariesTR8 Stock 12 Month Forecast
Average Price Target
€86.11
▲(15.59% Upside)
Technical Analysis
DXP Enterprises
―
EVI Industries
―
Distribution Solutions Group
―
Global Industrial Company
―
Titan Machinery
―